Advertisement

cancer talk

  • Cancer Treatment During a Pandemic

    People being treated for cancer may be at elevated risk of developing severe cases of COVID-19. The coronavirus is also affecting how cancer care is delivered.

    by William G. Nelson, MD, PhD

  • Testing Cancer Patients for the Coronavirus

    Cancer centers are taking advantage of their in-house molecular laboratories to selectively test certain cancer patients for the coronavirus.

    by Anna Azvolinsky

  • The Coronavirus Impacts Cancer Clinical Trials

    The National Cancer Institute and the Food and Drug Administration have provided guidance for managing clinical trials amid the spread of the novel coronavirus. Cancer centers are making changes to care for some patients enrolled in trials.

    by Anna Azvolinsky

  • A Unified Strategy

    A couple who lost their daughter to brain cancer builds a charity that connects parents, hospitals and researchers with data.

    by Marci A. Landsmann

  • The Coronavirus and Cancer Care

    Cancer patients in the U.S. are feeling impacts from the new coronavirus.

    by Kate Yandell

  • Medicare Coverage for Next-Generation Sequencing Tests

    Multigene panels that rely on next-generation sequencing are increasingly used to test for hereditary cancer risk-related mutations. The federal government aims to expand Medicare coverage for these tests.

    by Ashley P. Taylor

  • For Prostate Biopsy, It’s Best to Combine Old and New Methods

    Using an older method of prostate biopsy together with MRI-targeted biopsy more accurately diagnoses prostate cancer than either method alone, a study finds.

    by Kate Yandell

  • On Cancer and Identity

    The first time Liza Bernstein was diagnosed with cancer, she wouldn’t allow it to be part of her identity. After her third cancer diagnosis, she became an advocate for other patients.

    by Liza Bernstein

  • Despite Generic Imatinib, Cost of Treating CML Remains High

    The arrival of generic versions of the targeted therapy imatinib only modestly reduced the cost of treating chronic myelogenous leukemia patients, a study finds.

    by Anna Azvolinsky

  • Drinking After a Diagnosis

    A study illuminates the alcohol consumption habits of cancer survivors.

    by Jen Tota McGivney

Advertisement

Advertisement

From the AACR

Advertisement

Video

Handle With Care

Advertisement

social media

donate to the AACR